Hydrophilic polymers--biocompatibility testing in vitro

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Toxicology

Background:

• Biocompatibility is crucial for medical device safety, with cytotoxicity testing mandated by ISO standards.
• Hydrophilic polymers, specifically those based on 2-hydroxyethyl methacrylate (HEMA), are being explored for wound dressing applications.
• Incorporating antioxidants and free radical scavengers can potentially enhance the safety profile of these polymers.

Purpose of the Study:

• To evaluate the biocompatibility and suitability of HEMA-based polymers, with and without specific additives, for use as wound dressings.
• To assess the cytotoxicity and skin irritation potential of these modified polymers using in vitro models.
• To confirm in vitro findings with in vivo human skin tolerance testing.

Main Methods:

• In vitro cytotoxicity assessment using 3T3 Balb/c cell cultures via direct and indirect contact methods (3T3 NRU assay).
• Evaluation using a 3D human skin model (EpiDerm) for modified irritation testing.
• Testing the protective effect of HEMA polymer against a known irritant (sodium dodecyl sulfate).
• Confirmation of in vitro results through human local skin tolerance testing.

Main Results:

• HEMA-based polymers, both basic and those with added antioxidants (vitamin C, hindered amine stabilizer), demonstrated high biocompatibility.
• The tested polymers exhibited good skin tolerance in both in vitro models and human testing.
• HEMA polymer showed a protective effect against the cytotoxicity induced by sodium dodecyl sulfate.
• Enrichment with additives up to a balanced level maintained excellent biocompatibility.

Conclusions:

• HEMA-based hydrophilic polymers possess favorable biocompatibility and skin tolerance profiles.
• These polymers, particularly when optimized with specific antioxidant additives, are suitable for medical applications such as wound dressings.
• In vitro testing effectively predicts in vivo skin tolerance for these biomaterials.